Rheumatoid arthritis management Flashcards
Tretament prniciples
Treat to target - initiate DMARDs at diagnosis unless contraindication
Drugs initiate with diagnosis of rheumatoid arhteitis
Methotrexate
Short term glucocorticoids
NSAIDs
Alternatives to methotrexate if CI
Leflunomide
Sulfasalazine
When move from first stage of treatment to second RA
Fail to achieve improvement at 3 months and target at 6 months
Second line treatment rheumatoid
Change or add second conventional DMARD eg leflonomide, sulfasalzine, ethotrexate
JAK inhibitor
3rd line therapy rhueamtoid disease
Change the DMARD and replace with abatercept or IL-G inhibtiro, riflixumab or second TNF inhibitpr OR use JAK inhibtior
Screening before start DMARDs
Fretility, pregnancy, delivery
Baseline assess - weight, height, BP
Bloods - BC U+Es, LFTs, albumin
Screen for TB, HIV and hepatitis
Comorbidities - resp, occult infection
Flu and pneumococcal vaccines
DMARD counselling and education
What do with DMARDs in serious infection
Discontinue until reovered
Risks, cautions and side effects of biological DMARDs
Infection
Exacerbation of cardiac failure
Malignancy
Reactivation TB, hep B
Avoid live vaccines Demuelination, SLE like syndrome
What biologics use in high risk patient
Etanercept, abatercept
What caution with malignancy risk of DMARDs
Risk in SKIN cancer increases
Caution in patients w prev malignancy
JAK inhibitors vs bioloigcs advantage
Can take orally
How to achieve remission in rheumatoid arthritis
Aggressive, early targeted therapy
Aim for 50% patients sustained remission
Patient choice
Cause of rheumatoid
Large genetic influece